BioNTech has announced that it will apply for a license to use the coronavirus vaccine for the 5-11 age group in the coming weeks.
German biotechnology company BioNTech has announced that it will ask authorities in the coming weeks for permission to use the new type of vaccine against the coronavirus (Kovid-19) in children aged 5 to 11.
Speaking to the German magazine “Der Spiegel”, the founders of BioNTech Prof. Dr. Uğur Şahin and Dr. Özlem Türeci gave information on studies on the vaccination of children under 12 years of age with the corona virus.
Stating that they will present the results of their scientific study of children aged 5 to 11 around the world in the coming weeks to authorities around the world, Türeci said they will seek approval of a vaccine for this. age range, including in Europe.
Türeci said BioNTech has scientific research results for the age group in question, but these should be made available to institutions that have the power to authorize them.
Özlem Türeci, who is also the medical director of BioNTech, said: “We are already preparing for production. The vaccine will be the same, but in smaller doses. ‘Used the expression.
class = “cf”>
Uğur Şahin, on the other hand, said scientific studies of vaccines for the mentioned age group are going well and said, “The situation looks good. Everything is going as planned. ” noted.
Biontech founders Ahin and Türeci urged the company to do everything possible to convince those undecided about getting vaccinated to get vaccinated in the coming weeks.
Şahin said, “As a company, we still have 60 days to avoid a harsh winter. We must do our best to mobilize as many people as possible during these two months. He called.